The results of our analyses of CD133 expression in colon cancer are somewhat higher than that reported previously (1.8–25% O’Brien et al, 2007; Ricci-Vitiani et al, 2007) and more in accordance with those more recently reported by Shmelkov et al (2008) in primary human colon tumours. This evidence concerns the gene PROM1 and colonic neoplasm.